Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

GermanyBack to Germany

Clinical trials in Lohne (oldenburg)

4 clinical trials in Lohne (oldenburg), Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Lohne (oldenburg) at a glance
4
clinical trials
  • Recruiting now0
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Lohne (oldenburg)

Open in trial search

Psoriasis

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Alumis Inc.

Chronic spontaneous urticaria

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.

Psoriasis

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Brodalumab
  • Sponsor:LEO PHARMA A/S

Androgenetic alopecia

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Minoxidil
  • Sponsor:Industrial Farmaceutica Cantabria S.A.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Lohne (oldenburg)

What the registry says about research in the country

01 Lohne (oldenburg)
Skin and Connective Tissue Diseases
The clinical trial activity in Lohne (oldenburg) includes several studies focused on skin and connective tissue diseases, especially moderate to severe atopic dermatitis and moderate to severe plaque psoriasis. These trials are looking at whether new or adjusted treatments can better control symptoms and improve everyday skin health. Testing an oral treatment for atopic dermatitis Evaluating a new option for plaque psoriasis Comparing adjusted treatment approaches for people with higher body weight Assessing how well therapies reduce visible disease activity and discomfort Overall, this area is centered on improving treatment effectiveness and symptom relief for chronic inflammatory skin conditions.
Immune System Diseases
Research in immune system diseases is represented by a trial in chronic spontaneous urticaria, a condition that can cause recurring hives and intense itching. The main goal is to see whether a new therapy can better reduce disease activity than placebo. Studying chronic spontaneous urticaria Measuring changes in urticaria activity over time Testing a therapy aimed at improving symptom control Supporting better management of persistent allergic-type skin reactions This work reflects a broader effort to find more reliable options for patients living with difficult-to-control immune-mediated conditions.
Hormonal Diseases
The city’s trial portfolio also includes research in hormonal diseases, with a focus on female androgenetic alopecia. This study is examining whether a treatment strategy can improve hair growth and help address hormone-related hair loss in women. Investigating female androgenetic alopecia Assessing improvements in hair density and hair counts Comparing an active hair-loss treatment with control treatments Exploring better ways to manage hormone-related thinning hair These findings may help expand treatment choices for women seeking more effective care for progressive hair loss.
Back to GermanyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.